Fennec Pharmaceuticals Inc.
FENC
$9.04
$0.364.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.15M | -1.17M | -1.99M | -5.74M | -5.55M |
| Total Depreciation and Amortization | 25.00K | 26.00K | -774.00K | 25.00K | 26.00K |
| Total Amortization of Deferred Charges | 13.00K | 13.00K | 895.00K | 21.00K | 23.00K |
| Total Other Non-Cash Items | 2.64M | 878.00K | 338.00K | 6.25M | 1.33M |
| Change in Net Operating Assets | -3.21M | -4.07M | 52.00K | -2.76M | -4.21M |
| Cash from Operations | -3.69M | -4.32M | -1.47M | -2.21M | -8.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -13.00M | -- | -- |
| Issuance of Common Stock | -- | 371.00K | 797.00K | -- | 347.00K |
| Repurchase of Common Stock | -284.00K | -12.00K | -9.00K | -528.00K | -90.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -284.00K | 359.00K | -12.21M | -528.00K | 257.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.97M | -3.96M | -13.69M | -2.73M | -8.13M |